Highline Wealth Partners
CVS icon

Highline Wealth Partners’s CVS Health CVS Stock Holding History

Highline Wealth Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$63.5K Buy
741
+199
+37% +$19.5K 0.01% 230
2026
Q2 		$56.1K Buy
542
+188
+53% +$16.8K 0.01% 220
2026
Q1 		$25.4K Buy
354
+10
+3% +$770 0.01% 258
2025
Q4 		$27.3K Buy
344
+7
+2% +$552 0.01% 206
2025
Q3 		$25.4K Buy
337
+18
+6% +$1.23K 0.01% 234
2025
Q2 		$22K Sell
319
-8
-2% -$525 0.01% 214
2025
Q1 		$22.2K Buy
327
+163
+99% +$9.8K 0.01% 199
2024
Q4 		$7.36K Sell
164
-6,425
-98% -$360K ﹤0.01% 285
2024
Q3 		$414K Sell
6,589
-578
-8% -$33.7K 0.14% 81
2024
Q2 		$423K Sell
7,167
-2,434
-25% -$152K 0.16% 77
2024
Q1 		$766K Hold
9,601
– – 0.31% 60
2023
Q4 		$758K Buy
9,601
+5
+0.1% +$356 0.37% 62
2023
Q3 		$670K Buy
9,596
+2,039
+27% +$144K 0.41% 57
2023
Q2 		$522K Sell
7,557
-12
-0.2% -$854 0.33% 70
2023
Q1 		$562K Sell
7,569
-1
-0% -$84 0.38% 63
2022
Q4 		$705K Buy
7,570
+3
+0% +$289 0.52% 55
2022
Q3 		$722K Buy
+7,567
New +$749K 0.59% 44

Other funds holding CVS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Davis Selected Advisers
Davis Selected Advisers Tucson, Arizona $23.2B AUM 18.42% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Highline Wealth Partners's CVS Position: Q3 2026 in Review

Highline Wealth Partners increased its CVS Health (CVS) stake by 37% in Q3 2026, buying an estimated $19.5K and bringing the position to 741 shares worth $63.5K. The position accounts for 0.01% of the portfolio, ranked #230.

Highline Wealth Partners first reported a position in CVS in Q3 2022 and has held it in 17 quarters since. The position peaked at $766K in Q1 2024. 1,324 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Highline Wealth Partners held 741 shares of CVS Health worth $63.5K as of Q3 2026.
  • Highline Wealth Partners bought 199 CVS Health shares in Q3 2026, an estimated $19.5K.
  • CVS Health made up 0.01% of Highline Wealth Partners's portfolio in Q3 2026, its #230 holding.
  • Highline Wealth Partners first reported a position in CVS Health in Q3 2022 and has held it in 17 quarters since.
  • Highline Wealth Partners's CVS Health position peaked at $766K in Q1 2024.
  • 1,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.